Cargando…
中国真实世界慢性髓性白血病患者停用酪氨酸激酶抑制剂的观察研究
OBJECTIVE: This study aimed to observe whether the treatment-free remission（TFR）of second-generation tyrosine kinase inhibitors（TKI）in chronic myeloid leukemia（CML）is better than imatinib（IM）. METHODS: The clinical data of 274 CML patients who discontinued treatment and with complete clinical data w...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593009/ https://www.ncbi.nlm.nih.gov/pubmed/36709147 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.08.004 |